• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases.益生菌作为补充剂在预防和治疗传染病中的现状。
Front Cell Infect Microbiol. 2022 Mar 14;12:789063. doi: 10.3389/fcimb.2022.789063. eCollection 2022.
2
Salmonella infection - prevention and treatment by antibiotics and probiotic yeasts: a review.沙门氏菌感染——抗生素和益生菌酵母的预防与治疗:综述
Microbiology (Reading). 2018 Nov;164(11):1327-1344. doi: 10.1099/mic.0.000709. Epub 2018 Aug 23.
3
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation.益生菌在致病性感染期间的调节作用,重点是免疫调节。
Front Immunol. 2021 Apr 8;12:616713. doi: 10.3389/fimmu.2021.616713. eCollection 2021.
4
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2011 Nov 9(11):CD004827. doi: 10.1002/14651858.CD004827.pub3.
5
Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.口服益生菌辅助标准抗生素疗法治疗细菌性阴道病和需氧菌性阴道炎:一项随机、双盲、安慰剂对照试验
BMC Womens Health. 2015 Dec 3;15:115. doi: 10.1186/s12905-015-0246-6.
6
Use of probiotics in pediatric infectious diseases.益生菌在儿科感染性疾病中的应用。
Expert Rev Anti Infect Ther. 2015;13(12):1517-35. doi: 10.1586/14787210.2015.1096775. Epub 2015 Oct 23.
7
Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing to a Mixture of , and .住院期间使用抗生素治疗时使用益生菌是否能预防肠道微生物群定植多重耐药菌?一项比较 与 和 的随机安慰剂对照试验
Front Public Health. 2021 Mar 8;8:578089. doi: 10.3389/fpubh.2020.578089. eCollection 2020.
8
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2015 Dec 22(12):CD004827. doi: 10.1002/14651858.CD004827.pub4.
9
Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.益生菌对人类免疫缺陷病毒 1 型感染中微生物宿主防御、生长和免疫功能的影响。
Nutrients. 2011 Dec;3(12):1042-70. doi: 10.3390/nu3121042. Epub 2011 Dec 19.
10
Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.益生菌预防儿童抗生素相关性腹泻
Explore (NY). 2016 Nov-Dec;12(6):463-466. doi: 10.1016/j.explore.2016.08.015. Epub 2016 Aug 26.

引用本文的文献

1
The Impact of Synbiotics on the Bacterial Flora During the Course of Chronic Sinusitis.合生元对慢性鼻窦炎病程中细菌菌群的影响。
Medicina (Kaunas). 2025 Jul 20;61(7):1306. doi: 10.3390/medicina61071306.
2
Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.小儿血液系统恶性肿瘤异基因造血干细胞移植后感染性并发症的微生物群调节
Front Pediatr. 2025 Mar 14;13:1509612. doi: 10.3389/fped.2025.1509612. eCollection 2025.
3
Evaluation of Acute and Sub-Chronic Toxicity of GG in Sprague-Dawley Rats.GG对斯普拉格-道利大鼠的急性和亚慢性毒性评估。
Adv Biomed Res. 2024 Dec 28;13:126. doi: 10.4103/abr.abr_13_24. eCollection 2024.
4
Combating antimicrobial resistance in osteoarticular infections: Current strategies and future directions.对抗骨关节炎感染中的抗菌药物耐药性:当前策略与未来方向。
J Clin Orthop Trauma. 2024 Nov 2;58:102791. doi: 10.1016/j.jcot.2024.102791. eCollection 2024 Nov.
5
Microbiome modulators in the treatment of infectious diseases: insights from clinical trials.微生物组调节剂在传染病治疗中的应用:来自临床试验的见解
J Transl Med. 2024 Nov 18;22(1):1038. doi: 10.1186/s12967-024-05884-3.
6
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.益生菌的益处和担忧:产细胞毒素 colibactin 的 Nissle 1917 菌株潜在遗传毒性概述。
Gut Microbes. 2024 Jan-Dec;16(1):2397874. doi: 10.1080/19490976.2024.2397874. Epub 2024 Sep 4.
7
HAMLET, a human milk protein-lipid complex, modulates amoxicillin induced changes in an biofilm model of the oral microbiome.哈姆雷特(HAMLET)是一种人乳蛋白质 - 脂质复合物,可调节阿莫西林在口腔微生物群生物膜模型中引起的变化。
Front Microbiol. 2024 Jul 4;15:1406190. doi: 10.3389/fmicb.2024.1406190. eCollection 2024.
8
Prevention and treatment of antibiotics-associated adverse effects through the use of probiotics: A review.通过使用益生菌预防和治疗抗生素相关不良反应:综述
J Adv Res. 2025 May;71:209-226. doi: 10.1016/j.jare.2024.06.006. Epub 2024 Jun 4.
9
Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis.益生菌作为辅助治疗各种感染的作用:系统评价和荟萃分析。
BMC Infect Dis. 2024 May 21;24(1):505. doi: 10.1186/s12879-024-09259-3.
10
Novel Probiotic Candidates in Artisanal Feta-Type Kefalonian Cheese: Unveiling a Still-Undisclosed Biodiversity.传统法制作的凯法利尼亚菲达型奶酪中的新型益生菌候选菌株:揭示尚未公开的生物多样性
Probiotics Antimicrob Proteins. 2024 Mar 13. doi: 10.1007/s12602-024-10239-x.

本文引用的文献

1
Selection of Probiotics in the Prevention of Respiratory Tract Infections and Their Impact on Occupational Health: Scoping Review.益生菌在预防呼吸道感染中的选择及其对职业健康的影响:范围综述。
Nutrients. 2021 Dec 10;13(12):4419. doi: 10.3390/nu13124419.
2
Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?新型冠状病毒肺炎患者的营养与益生菌治疗:2021 年我们了解多少?
Nutrients. 2021 Sep 26;13(10):3385. doi: 10.3390/nu13103385.
3
Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?益生菌和益生元:COVID-19 营养管理的潜在预防和治疗靶点?
Nutr Res Rev. 2023 Dec;36(2):181-198. doi: 10.1017/S0954422421000317. Epub 2021 Oct 20.
4
Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.人类口咽微生物组在 SARS-CoV-2 感染及康复患者中的特征。
Adv Sci (Weinh). 2021 Oct;8(20):e2102785. doi: 10.1002/advs.202102785. Epub 2021 Aug 22.
5
Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.口咽益生菌ENT-K12预防抗击新冠疫情一线医护人员呼吸道感染的初步研究
Front Bioeng Biotechnol. 2021 Jun 24;9:646184. doi: 10.3389/fbioe.2021.646184. eCollection 2021.
6
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.口腔微生物群失调与COVID-19患者的症状严重程度及局部免疫/炎症反应相关:一项横断面研究。
Front Microbiol. 2021 Jun 23;12:687513. doi: 10.3389/fmicb.2021.687513. eCollection 2021.
7
Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.益生菌、益生元和合生菌:对肠易激综合征的影响和有益作用。
Nutrients. 2021 Jun 20;13(6):2112. doi: 10.3390/nu13062112.
8
Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy.胃癌患者胃切除术后益生菌化合物的辅助治疗及分子机制。
Food Funct. 2021 Jul 21;12(14):6294-6308. doi: 10.1039/d1fo01375k. Epub 2021 May 30.
9
Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.宏基因组分析揭示 COVID-19 患者口咽微生物群的改变。
Signal Transduct Target Ther. 2021 May 13;6(1):191. doi: 10.1038/s41392-021-00614-3.
10
The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection.给儿童施用唾液链球菌K12可能会降低新冠病毒感染率。
Minerva Med. 2021 Aug;112(4):514-516. doi: 10.23736/S0026-4806.21.07487-5. Epub 2021 Mar 12.

益生菌作为补充剂在预防和治疗传染病中的现状。

Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases.

机构信息

Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China.

出版信息

Front Cell Infect Microbiol. 2022 Mar 14;12:789063. doi: 10.3389/fcimb.2022.789063. eCollection 2022.

DOI:10.3389/fcimb.2022.789063
PMID:35360101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964067/
Abstract

Probiotics play an important role against infectious pathogens their effects on the epithelium, the production of antimicrobial compounds, and competitive exclusion. Administration of probiotic supplements may reduce the risk of infectious diseases and the use of antibiotics, hence contributing to a reduction or a delay of the development of multi-resistant bacteria. Infection is a constant concern for people who experience recurrent infections, and antibiotic treatment usually fails due to antibiotic resistance. Therefore, an infection can lead to severe illness and hospitalization if left untreated. A growing number of studies have demonstrated promising results for a variety of probiotic strains used to prevent or treat acute and recurrent infectious diseases, but additional standardized clinical research is needed.

摘要

益生菌在对抗感染性病原体方面发挥着重要作用,其作用机制包括对上皮细胞的影响、抗菌化合物的产生和竞争性排斥。益生菌补充剂的使用可能会降低感染性疾病和抗生素使用的风险,从而有助于减少或延缓多药耐药菌的产生。对于经常发生感染的人来说,感染是一个持续存在的问题,而且由于抗生素耐药性,抗生素治疗通常会失败。因此,如果不进行治疗,感染可能会导致严重疾病和住院治疗。越来越多的研究表明,多种益生菌菌株在预防和治疗急性和复发性传染病方面具有良好的效果,但需要进行更多标准化的临床研究。